✦ LIBER ✦

Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells

✍ Scribed by Jack F. Youngren; Karissa Gable; Cristina Penaranda; Betty A. Maddux; Marianna Zavodovskaya; Margaret Lobo; Michael Campbell; John Kerner; Ira D. Goldfine

Publisher: Springer US
Year: 2005
Tongue: English
Weight: 330 KB
Volume: 94
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-005-6939-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nordihydroguaiaretic acid (NDGA), an inh

Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells

✍ Marianna Zavodovskaya; Michael J. Campbell; Betty A. Maddux; Laura Shiry; Geoffr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

## Abstract We have reported that nordihydroguaiaretic acid (NDGA) inhibits the tyrosine kinase activities of the IGF‐1 receptor (IGF‐1R) and the HER2 receptor in breast cancer cells. Herein, we studied the effects of NDGA on the growth of estrogen receptor (ER) positive MCF‐7 cells engineered to o

Bidirectional interactions between the e

Bidirectional interactions between the estrogen receptor and the c-erbB-2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells

✍ Thomas W. Grunt; Miguel Saceda; Mary Beth Martin; Ruth Lupu; Evelyn Dittrich; Ge 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 993 KB

The responsiveness of estrogen receptor (ER)-positive breast cancer to endocrine therapy is frequently reduced in cells over-expressing c-erbB-2. Stimulation of ER suppresses c-erbB-2, indicating that estrogen controls the activity of c-erbB-2. Heregulin (HRG) has been described to bind to c-erbB-3/